000 | 01958 a2200553 4500 | ||
---|---|---|---|
005 | 20250516063016.0 | ||
264 | 0 | _c20120103 | |
008 | 201201s 0 0 eng d | ||
022 | _a1474-547X | ||
024 | 7 |
_a10.1016/S0140-6736(11)61095-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarde, Padraig | |
245 | 0 | 0 |
_aCombined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. _h[electronic resource] |
260 |
_bLancet (London, England) _cDec 2011 |
||
300 |
_a2104-11 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aOrchiectomy |
650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMason, Malcolm | |
700 | 1 | _aDing, Keyue | |
700 | 1 | _aKirkbride, Peter | |
700 | 1 | _aBrundage, Michael | |
700 | 1 | _aCowan, Richard | |
700 | 1 | _aGospodarowicz, Mary | |
700 | 1 | _aSanders, Karen | |
700 | 1 | _aKostashuk, Edmund | |
700 | 1 | _aSwanson, Greg | |
700 | 1 | _aBarber, Jim | |
700 | 1 | _aHiltz, Andrea | |
700 | 1 | _aParmar, Mahesh K B | |
700 | 1 | _aSathya, Jinka | |
700 | 1 | _aAnderson, John | |
700 | 1 | _aHayter, Charles | |
700 | 1 | _aHetherington, John | |
700 | 1 | _aSydes, Matthew R | |
700 | 1 | _aParulekar, Wendy | |
773 | 0 |
_tLancet (London, England) _gvol. 378 _gno. 9809 _gp. 2104-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(11)61095-7 _zAvailable from publisher's website |
999 |
_c21285913 _d21285913 |